Returning more cash than it generates. Paid out $1.9B vs $1.3B of free cash flow over the 3 fiscal years to 2025.
DuPont de Nemours returned $1.9B to shareholders over three years, 151% of the free cash flow it produced. That gap has to be covered by cash reserves or new debt, which can't last indefinitely.
Earnings turned from a loss to a profit. Profit per share this year after a loss last year.
DuPont de Nemours made a profit per share in its latest year after a loss the year before.
Sales growing faster than profits. Since 2022: revenue −47%, operating profit −85%.
Since 2022, DuPont de Nemours's revenue changed −47% while operating profit fell 85%: costs rose faster than sales.
Fast revenue growth. Revenue grew 76% in the 12 months to June 2026 vs the 12 months before, faster than 95% of peers.
Revenue grew 76% in the 12 months to June 2026 vs the 12 months before, faster than 95% of its peers.
StockQuotient Score
58/ 100▼ 1 since Oct 27 closeOct 5 60 → Nov 4 58 (-2)
Since last quarter: No major changeValuation also moves with the share price every day.
Why it changed since the Oct 27, 2026 close: Score 47 → 43
Share price +11.5%-3
Peer companies moved-1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Why it changed since the Oct 27, 2026 close: Score 89 → 90
Peer companies moved+1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about DuPont de Nemours
Is DuPont de Nemours getting weaker?
Its latest SEC filing (Aug 4, 2026) showed no major changes. Its overall score is 58/100, down 1 since Oct 28, 2026.
How is DuPont de Nemours valued vs its peers?
Priced about in line with its peers. Valuation scores 43/100 against 1,371 basic materials peers.EBITDA yield 5.0% vs a peer median of 8.5% (weaker than 67% of peers).EBITDA yield 5.0% vs peers 8.5% (weaker than 67% of peers).
Is DuPont de Nemours growing?
Yes, faster than most of its peers. Growth scores 90/100 against 1,371 basic materials peers.Revenue growth 75.7% vs a peer median of 3.4% (stronger than 95% of peers).Revenue growth 75.7% vs peers 3.4% (stronger than 95% of peers).3-year revenue growth -17.7% vs a peer median of -0.0% (weaker than 94% of peers).3-year revenue growth -17.7% vs peers -0.0% (weaker than 94% of peers).
How profitable is DuPont de Nemours?
About as profitable as its peers. Profitability scores 47/100 against 1,371 basic materials peers.Return on assets 4.4% vs a peer median of 2.5% (stronger than 68% of peers).Return on assets 4.4% vs peers 2.5% (stronger than 68% of peers).Return on invested capital 2.5% vs a peer median of 6.7% (weaker than 71% of peers).Return on invested capital 2.5% vs peers 6.7% (weaker than 71% of peers).
How risky is DuPont de Nemours?
Moderate risk relative to 1,371 basic materials peers, judged on debt, liquidity and share-price swings.Current ratio 2.43× vs a peer median of 1.76× (stronger than 69% of peers).Current ratio 2.43× vs peers 1.76× (stronger than 69% of peers).Beta 1.08 vs a peer median of 0.69 (weaker than 77% of peers).Beta 1.08 vs peers 0.69 (weaker than 77% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Aug 4, 2026 · compared with the quarter ended Mar 31, 2026
No major changes
Previous quarter
Latest quarter
Change
Revenue (12 months)
6.9B USD
7.0B USD
+1.0%
Net income (12 months)
838.0M USD
922.0M USD
+10.0%
Operating margin
4.8%
6.7%
+1.9 pts
Free cash flow (12 months)
402.0M USD
702.0M USD
+74.6%
Debt
3.2B USD
3.1B USD
−1.5%
Cash
710.0M USD
1.7B USD
+145.1%
Shares outstanding
136.6M
135.0M
−1.2%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Industry: Specialty Chemicals · 32 companies
Valuations in Specialty Chemicals are above their usual range since 2016.
74% of months since 2016 were valued lower than now.
17% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −8% and earnings +13% (medians): earnings grew faster than prices.
Median price-to-sales is −36% vs the whole market, against a usual −31%.
2016Shaded: most expensive fifth of its range2026
This is a cyclical group: after a downturn, trailing earnings and sales fall faster than prices, which can make valuations look high near a cycle's low.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on earnings, EBITDA, sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Operating margin
10.3%
9.7%
-5.4%
3.4%
2.7%
▼ 0.7 pts
Net margin
51.5%
45.1%
6.4%
10.5%
-11.4%
▼ 22 pts
Return on assets (ROA)
14.1%
14.2%
1.1%
1.9%
-3.6%
▼ 5.5 pts
Return on equity (ROE)
24.5%
22.1%
1.7%
3.0%
-5.6%
▼ 8.6 pts
Free cash flow margin
11.9%
-0.6%
8.2%
7.1%
3.3%
▼ 3.8 pts
Current ratio
2.90×
3.02×
2.43×
3.78×
2.42×
▼ 36%
Quick ratio
2.48×
2.40×
1.73×
3.57×
1.91×
▼ 47%
Debt to equity
0.41×
0.31×
0.32×
0.31×
0.23×
▼ 25%
DD price history
Price history is added with the daily price update and will appear after the next one.